Company news

Adherium Ltd. news in 2024

Adherium Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Management Change

October 29, 2024

AstraZeneca selected Adherium Smartinhaler for its study

May 23, 2024

Non-Renounceable Rights Issue Offer Completes

May 23, 2024

Placement and Entitlement Offer to raise up to $8.37 million

April 26, 2024

First Patient Enrolled in Major e-health Clinical Study

March 19, 2024

Adherium receives $1.5m Australian R&D Tax Rebate

March 6, 2024

New CEO Appointed - Dr Paul Mastoridis

January 31, 2024

Resignation of CEO

January 15, 2024

Decks in 2024